Clever Culture Systems Limited
CC5
Rank in Stocks
#27508
Based in Adelaide, Australia, Clever Culture Systems Limited, established in... Based in Adelaide, Australia, Clever Culture Systems Limited, established in 2004, focuses on the innovation, development, and market launch of advanced technological solutions for the medical industry. The company operates internationally, serving markets in Australia, the United States, Sweden, the United Kingdom, China, the Netherlands, and Germany. Its core offering is the Automated Plate Assessment System (APAS), which efficiently images, analyzes, and interprets microbiology culture plates, primarily assisting microbiology laboratories and the pharmaceutical manufacturing sector. The company's portfolio also includes Digital Microbiology and specialized APAS modules—artificial intelligence algorithms designed to enable digital reading of culture plates when integrated with the APAS Independence system. Additionally, Clever Culture Systems is advancing its APAS intelligent imaging technology for diverse applications, including urine screening, infection control testing, and assessing antimicrobial susceptibility. Formerly known as LBT Innovations Limited, the company adopted its current name in November 2024.
Share Price
$0.0141057
Last synced: 2026-10-20
Market Cap
$30.78M
Change (1 day)
0.00%
Change (1 year)
32.83%
Country
AU
Trade Clever Culture Systems Limited (CC5)
Category
Healthcare
Revenue for Clever Culture Systems Limited (CC5)
Revenue in Jun 2024 TTM: $838.62K
According to Clever Culture Systems Limited latest financial reports the company's current revenue (TTM) is $838.62K. In 2023 the company made a revenue of $1.42M a decrease compared to the revenue in the year 2022 that was $1.47M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Clever Culture Systems Limited from 2007 to 2026
Revenue at the end of each year
| Year | Revenue | Change |
|---|---|---|
| 2026 (TTM) | $838.62K | 0.00% |
| 2024 | $838.62K | -40.96% |
| 2023 | $1.42M | -3.22% |
| 2022 | $1.47M | 74.31% |
| 2021 | $842.03K | 5.02% |
| 2020 | $801.78K | 281.82% |
| 2019 | $209.99K | -70.19% |
| 2018 | $704.34K | 177.17% |
| 2017 | $254.12K | -95.58% |
| 2016 | $5.76M | 215.82% |
| 2015 | $1.82M | -51.59% |
| 2014 | $3.76M | -5.06% |
| 2013 | $3.97M | 360.75% |
| 2012 | $860.56K | 60.52% |
| 2011 | $536.12K | -83.24% |
| 2010 | $3.20M | 98.41% |
| 2009 | $1.61M | -10.05% |
| 2008 | $1.79M | -37.82% |
| 2007 | $2.88M | 0.00% |
Revenue for similar companies or competitors
| Company | Revenue | Revenue Difference | Country |
|---|---|---|---|
| $46.34B | 5,525,135.84% |
US
|
|
| $25.11B | 2,993,729.77% |
US
|
|
| $2.71B | 322,699.53% |
US
|
|
| - | - |
CN
|
|
| $7.37B | 878,958.15% |
US
|
